192 related articles for article (PubMed ID: 8291455)
1. 24-hour serum cortisol profiles in women with polycystic ovary syndrome.
Prelević GM; Würzburger MI; Balint-Perić L
Gynecol Endocrinol; 1993 Sep; 7(3):179-84. PubMed ID: 8291455
[TBL] [Abstract][Full Text] [Related]
2. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
3. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
4. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
[TBL] [Abstract][Full Text] [Related]
5. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Kocełak P; Janowska J; Semik-Grabarczyk E
Endokrynol Pol; 2008; 59(1):13-7. PubMed ID: 18335395
[TBL] [Abstract][Full Text] [Related]
6. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
7. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
Bernasconi D; Del Monte P; Meozzi M; Randazzo M; Marugo A; Badaracco B; Marugo M
Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
[TBL] [Abstract][Full Text] [Related]
8. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
[TBL] [Abstract][Full Text] [Related]
10. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
Orio F; Palomba S; Colao A; Russo T; Dentico C; Tauchmanovà L; Savastano S; Nappi C; Sultan C; Zullo F; Lombardi G
J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
[TBL] [Abstract][Full Text] [Related]
11. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Güneş M; Bukan N
Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
Mejia-Montilla J; Álvarez-Mon M; Reyna-Villasmil E; Torres-Cepeda D; Santos-Bolívar J; Reyna-Villasmil N; Suarez-Torres I; Bravo-Henríquez A
Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
[TBL] [Abstract][Full Text] [Related]
14. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
[TBL] [Abstract][Full Text] [Related]
15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
16. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
Kiddy DS; Sharp PS; White DM; Scanlon MF; Mason HD; Bray CS; Polson DW; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
18. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
Chapman IM; Wittert GA; Norman RJ
Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
[TBL] [Abstract][Full Text] [Related]
19. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome.
Roelfsema F; Kok P; Pereira AM; Pijl H
J Clin Endocrinol Metab; 2010 Jul; 95(7):3318-24. PubMed ID: 20410226
[TBL] [Abstract][Full Text] [Related]
20. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]